Literature DB >> 35198275

Deep Vein Thrombosis in Lepromatous Leprosy: A Case Report of Secondary Pediatric Antiphospholipid Syndrome.

Dyna Jones1, Jayashankar Ca2, Amey Joshi1, Shalini As3, Hemanth Kumar1.   

Abstract

Antiphospholipid syndrome (APS) is a rare autoimmune disorder characterized by thromboembolic events, fetal loss during pregnancy, and evidence of antiphospholipid (aPL) antibodies such as beta-2-glycoprotein I (B2-GPI) and anticardiolipin (aCL). The diagnosis and treatment of this condition in the pediatric population have limited literature evidence due to the rarity of the condition in this age group. Guidelines have been adopted from the adult counterpart of the affected population, thereby giving rise to diagnostic and therapeutic challenges. In this report, we describe a rare case of a 15-year-old male who presented with lepromatous leprosy and developed deep vein thrombosis in his right leg. The laboratory evidence of positive aPL antibodies guided our diagnosis of APS and treatment with oral anticoagulants. This report highlights the importance of screening and timely diagnosis of APS in the pediatric population presenting with venous thrombosis in the backdrop of infection.
Copyright © 2022, Jones et al.

Entities:  

Keywords:  antiphospholipid syndrome; autoimmune; deep vein thrombosis; leprosy; pediatric

Year:  2022        PMID: 35198275      PMCID: PMC8853942          DOI: 10.7759/cureus.21361

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Antiphospholipid syndrome: critical analysis of the diagnostic path.

Authors:  V Pengo; A Banzato; E Bison; G Denas; S Padayattil Jose; A Ruffatti
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

Review 2.  The pathogenesis of the antiphospholipid syndrome.

Authors:  Bill Giannakopoulos; Steven A Krilis
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

Review 3.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

Review 4.  European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative.

Authors:  Noortje Groot; Nienke de Graeff; Tadej Avcin; Brigitte Bader-Meunier; Pavla Dolezalova; Brian Feldman; Gili Kenet; Isabelle Koné-Paut; Pekka Lahdenne; Stephen D Marks; Liza McCann; Clarissa A Pilkington; Angelo Ravelli; Annet van Royen-Kerkhof; Yosef Uziel; Sebastiaan J Vastert; Nico M Wulffraat; Seza Ozen; Paul Brogan; Sylvia Kamphuis; Michael W Beresford
Journal:  Ann Rheum Dis       Date:  2017-05-04       Impact factor: 19.103

Review 5.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

6.  The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study.

Authors:  Ali Duarte-García; Michael M Pham; Cynthia S Crowson; Shreyasee Amin; Kevin G Moder; Rajiv K Pruthi; Kenneth J Warrington; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2019-08-01       Impact factor: 10.995

7.  High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.

Authors:  G F de Larrañaga; R R Forastiero; M E Martinuzzo; L O Carreras; G Tsariktsian; M M Sturno; B S Alonso
Journal:  Lupus       Date:  2000       Impact factor: 2.911

8.  Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.

Authors:  Tadej Avcin; Rolando Cimaz; Earl D Silverman; Ricard Cervera; Marco Gattorno; Stella Garay; Yackov Berkun; Flavio R Sztajnbok; Clovis A Silva; Lucia M Campos; Claudia Saad-Magalhaes; Donato Rigante; Angelo Ravelli; Alberto Martini; Blaz Rozman; Pier Luigi Meroni
Journal:  Pediatrics       Date:  2008-10-27       Impact factor: 7.124

Review 9.  Antiphospholipid syndrome.

Authors:  Lisa R Sammaritano
Journal:  Best Pract Res Clin Rheumatol       Date:  2019-12-19       Impact factor: 4.098

Review 10.  The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.

Authors:  Chris Wincup; Yiannis Ioannou
Journal:  Front Pediatr       Date:  2018-11-27       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.